JP Stock MarketDetailed Quotes

4884 Kringle Pharma

Watchlist
  • 822
  • -4-0.48%
20min DelayMarket Closed Apr 25 15:30 JST
5.62BMarket Cap-6.95P/E (Static)

About Kringle Pharma Company

Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases.

Company Profile

Symbol4884
Company NameKringle Pharma
Founded2001-12-21
MarketTSE Growth
Fiscal Year Ends09-30
Address7-7-15 Saitoasagi 207 Saito Bio-Incubator
Zip Code567-0085
Phone072-641-8739

Company Executives

  • Name
  • Position
  • Salary
  • Yoshikazu Adachi
  • President and Chief Executive Officer
  • --
  • Yoshiyuki Kayano
  • Director, General Manager of Reliability Assurance Department
  • --
  • Koichi Murakami
  • Director and General Manager of Corporate Administration
  • --
  • Daima Hayata
  • Director, General Manager of Pharmaceutical Development Department and General Manager of Pharmaceutical Affairs Department
  • --
  • Tomoho Masataku
  • Director
  • --
  • Masato Fukui
  • Independent Director
  • --
  • Koichiro Yoshino
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More